Risedronic acid en es it fr

Risedronic acid Brand names, Risedronic acid Analogs

Risedronic acid Brand Names Mixture

  • No information avaliable

Risedronic acid Chemical_Formula


Risedronic acid RX_link


Risedronic acid fda sheet

Risedronic_acid FDA

Risedronic acid msds (material safety sheet)

Risedronic_acid MSDS

Risedronic acid Synthesis Reference

No information avaliable

Risedronic acid Molecular Weight

283.112 g/mol

Risedronic acid Melting Point

No information avaliable

Risedronic acid H2O Solubility

No information avaliable

Risedronic acid State


Risedronic acid LogP

No information avaliable

Risedronic acid Dosage Forms


Risedronic acid Indication

For the treatment of Paget's disease of the bone (osteitis deformans), postmenopausal and glucocorticoid-induced osteoporosis

Risedronic acid Pharmacology

Risedronate is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism and is indicated for the treatment and prevention of osteoporosis in postmenopausal women.

Risedronic acid Absorption

Rapid absorption (~1 hr) after an oral dose, occurs throughout the upper gastrointestinal tract

Risedronic acid side effects and Toxicity

Side effects include abdominal pain, anxiety, back pain, belching, bladder irritation, bone disorders and pain, bronchitis, bursitis, cataracts, chest pain, colitis, constipation, depression, diarrhea, difficulty breathing, dizziness, dry eyes, eye infection, flu-like symptoms, gas, headache, high blood pressure, infection, insomnia, itching, joint disorders and pain, leg cramps, muscle pain, muscle weakness, nausea, neck pain, nerve pain, pain, pneumonia, rash, ringing in ears, sinus problems, sore throat, stomach bleeding, stuffy or runny nose, swelling, tendon problems, tumor, ulcers, urinary tract infection, vertigo, vision problems, and weakness.

Risedronic acid Patient Information

No information avaliable

Risedronic acid Organisms Affected

Humans and other mammals